Price History
Feb 9, 2026 — May 7, 2026Investment Snapshot
- P/B of 0.58 — trading below book value
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -65.4%
- Revenue declining 55% annually
Evogene Ltd. - Ordinary Shares (EVGN) is a Basic Materials company operating in Agricultural Chemicals, listed on the NASDAQ , with a market capitalisation of $7 million . Key value metrics: P/B ratio 0.58, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Evogene Ltd. - Ordinary Shares — Fundamental Analysis Summary
On financial health, EVGN shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -65.4% (sector average: -1.2%), and elevated leverage with a debt-to-equity ratio of 1.74.
StockPik's composite Value Score for EVGN is 50/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EVGN reports a thin gross margin of -6.3% (sector average: 33.0%) and a negative operating margin of -364.2%.
EVGN shows revenue declining at 55% year-over-year, with earnings growing at 57%.